A Bayesian framework for cell-level protein network analysis for multivariate proteomics image data

2014 ◽  
Author(s):  
Violet N. Kovacheva ◽  
Korsuk Sirinukunwattana ◽  
Nasir M. Rajpoot
2013 ◽  
Vol 30 (3) ◽  
pp. 420-427 ◽  
Author(s):  
Violeta N. Kovacheva ◽  
Adnan M. Khan ◽  
Michael Khan ◽  
David B. A. Epstein ◽  
Nasir M. Rajpoot

2020 ◽  
Vol 27 (5) ◽  
pp. 729-737
Author(s):  
Lei Li ◽  
Linhua Jiang ◽  
Sihua Peng

2007 ◽  
Vol 104 (16) ◽  
pp. 6579-6584 ◽  
Author(s):  
O. Sahin ◽  
C. Lobke ◽  
U. Korf ◽  
H. Appelhans ◽  
H. Sultmann ◽  
...  

2011 ◽  
Vol 40 (D1) ◽  
pp. D465-D471 ◽  
Author(s):  
J. Lees ◽  
C. Yeats ◽  
J. Perkins ◽  
I. Sillitoe ◽  
R. Rentzsch ◽  
...  

Author(s):  
I. E. Nadezhdina ◽  
A. E. Zubarev ◽  
E. S. Brusnikin ◽  
J. Oberst

A new global control point network was derived for Enceladus, based on Cassini and Voyager-2 image data. Cassini images were taken from 2005 to 2014, for Voyager we have only one flyby in the middle of 1981. We have derived 3D Cartesian coordinates for 1128 control points as well as improved pointing data for 12 Voyager and 193 Cassini images in the Enceladus-fixed coordinate system. The point accuracies vary from 55 m to 2900 m (average point accuracy – 221 m). From tracking of the control points we detect a librational motion described by a model which includes 3 different periods and amplitudes (Rambaux et al., 2011). We determine the amplitudes for each term. Our new control point network has a higher number of point measurements and a higher accuracy than previous data (Giese et al., 2014).


2008 ◽  
Vol S2 (01) ◽  
pp. 056-057
Author(s):  
A. R. White ◽  
T. Du ◽  
L. Bica ◽  
A. Caragounis ◽  
K. A. Price ◽  
...  

2020 ◽  
Author(s):  
seyedeh zahra mousavi ◽  
mojdeh rahmanian ◽  
ashkan sami

<div>Aims: The recent outbreak of COVID-19 has become a global health concern. There are currently no effective treatment strategies and vaccines for the treatment or prevention of this fatal disease. The current study aims to determine promising treatment options for the COVID-19 through a computational drug repurposing approach.</div><div>Materials and methods: In this study, we focus on differentially expressed genes (DEGs), detected in SARS-CoV-2 infected cell lines including “the primary human lung epithelial cell line NHBE” and “the transformed lung alveolar cell line A549”. Next, the identified DEGs are used in the connectivity map (CMap) analysis to identify similarly acting therapeutic candidates. Furthermore, to interpret lists of DEGs, pathway enrichment and protein network analysis are performed. Genes are categorized into easily interpretable pathways based on their biological functions, and overrepresentations of each pathway are tested in comparison to what is expected randomly.</div><div>Key findings: The results suggest the effectiveness of Saquinavir, lansoprazole, folic acid, ebselen, aminocaproic acid, simvastatin, surfactant stimulant drugs, heat shock protein 90 (HSP90) inhibitors, histone deacetylase (HDAC) inhibitors, metronidazole, inhaled corticosteroids (ICS) and many other clinically approved drugs and investigational compounds as potent drugs against COVID-19 outbreak.</div><div>Significance: Making new drugs remain a lengthy process, so the drug repurposing approach provides an insight into the therapeutics that might be helpful in this pandemic. In this study, pathway enrichment and protein network analysis are also performed, and the effectiveness of some drugs obtained from the CMap analysis has been investigated according to previous research.</div>


Sign in / Sign up

Export Citation Format

Share Document